This Rockville biotech has added another deal to its growth plan
September 09, 2019 at 12:58 PM EDT
The deal gives RegenxBio an option for exclusive, worldwide commercial licensing rights to the biopharma’s SCS Microinjector, its delivery method for gene therapies.
